Publications by authors named "Erik D Brady"

Claim this Profile
T
The SMARTIE Program: A Novel Initiative to Evaluate the Impact of AP Continuing Education on Clinical Practice.
Sandra E Kurtin, Constance Visovsky, Erik D Brady, Alana L K Brody

J Adv Pract Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Writing Multiple Choice Outcome Questions to Assess Knowledge and Competence.
Erik D Brady

J Contin Educ Nurs· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved efficacy of alpha-particle-targeted radiation therapy: dual targeting of human epidermal growth factor receptor-2 and tumor-associated glycoprotein 72.
Diane E Milenic, Erik D Brady, Kayhan Garmestani, Paul S Albert, Alia Abdulla

Cancer· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality therapy: potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease.
Diane E Milenic, Kayhan Garmestani, Erik D Brady, Kwamena E Baidoo, Paul S Albert

Clin Cancer Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI.
Hyun-Soon Chong, Hyun A Song, Xiang Ma, Diane E Milenic, Erik D Brady

Bioconjug Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy.
Hyun-Soon Chong, Xiang Ma, Thien Le, Baidoo Kwamena, Diane E Milenic, Erik D Brady

J Med Chem· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal disease.
Diane E Milenic, Kayhan Garmestani, Erik D Brady, Paul S Albert, Alia Abdulla

Clin Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo evaluation of novel ligands for radioimmunotherapy.
Hyun-Soon Chong, Diane E Milenic, Kayhan Garmestani, Erik D Brady, Hans Arora

Nucl Med Biol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Hyun-Soon Chong, Kayhan Garmestani, L Henry Bryant, Diane E Milenic, Terrish Overstreet, Erik D Brady

J Med Chem· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a (212)Pb-labeled radioimmunoconjugate targeting HER2.
Diane E Milenic, Kayhan Garmestani, Erik D Brady, Paul S Albert, Dangshe Ma

Cancer Biother Radiopharm· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purification of cyclotron-produced 203Pb for labeling Herceptin.
Kayhan Garmestani, Diane E Milenic, Erik D Brady, Paul S Plascjak, Martin W Brechbiel

Nucl Med Biol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of HER2 antigen for the treatment of disseminated peritoneal disease.
Diane E Milenic, Kayhan Garmestani, Erik D Brady, Paul S Albert, Dangshe Ma

Clin Cancer Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a spectroscopic assay for bifunctional ligand-protein conjugates based on copper.
Erik D Brady, Hyun-Soon Chong, Diane E Milenic, Martin W Brechbiel

Nucl Med Biol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody guided precision radiation therapy.
Erik D Brady, Diane E Milenic, Martin W Brechbiel

Discov Med· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-targeted radiation cancer therapy.
Diane E Milenic, Erik D Brady, Martin W Brechbiel

Nat Rev Drug Discov· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher order speciation effects on plutonium L(3) X-ray absorption near edge spectra.
Steven D Conradson, Kent D Abney, Bruce D Begg, Erik D Brady, David L Clark

Inorg Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tris(bis(trimethylsilyl)amido)samarium: X-ray structure and DFT study.
Erik D Brady, David L Clark, John C Gordon, P Jeffrey Hay, D Webster Keogh

Inorg Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spin-state alteration from sterically enforced ligand rotation in bis(indenyl)chromium(II) complexes.
Erik D Brady, Jason S Overby, M Brett Meredith, Adam B Mussman, Michael A Cohn

J Am Chem Soc· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mechanistic study of the samarium(II)-mediated reduction of aryl nitro compounds to the corresponding crylamines. The crystal structures of [Sm[N(SiMe(3))(2)](2)(thf)](2)(mu(2)-O) and [(Me(3)Si)(2)N](2)Sm(thf)(mu-PhNNPh)Sm[N(SiMe(3))(2)](2).
Erik D Brady, David L Clark, D Webster Keogh, Brian L Scott, John G Watkin

J Am Chem Soc· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis